Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29100190

Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2017 Nov
First author
Geoerger B

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Eur J Cancer. 2018 May;95:117-119. doi: 10.1016/j.ejca.2018.01.080.
    note
    Source null
    related pmid
    29475773
    relationship
    Comment in

Authors and identifiers

  1. name
    Geoerger B
    type
    Author
  2. name
    Bergeron C
    type
    Author
  3. name
    Gore L
    type
    Author
  4. name
    Sender L
    type
    Author
  5. name
    Dunkel IJ
    type
    Author
  6. name
    Herzog C
    type
    Author
  7. name
    Brochez L
    type
    Author
  8. name
    Cruz O
    type
    Author
  9. name
    Nysom K
    type
    Author
  10. name
    Berghorn E
    type
    Author
  11. name
    Simsek B
    type
    Author
  12. name
    Shen J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Geoerger B
    type
    Author
  2. name
    Bergeron C
    type
    Author
  3. name
    Gore L
    type
    Author
  4. name
    Sender L
    type
    Author
  5. name
    Dunkel IJ
    type
    Author
  6. name
    Herzog C
    type
    Author
  7. name
    Brochez L
    type
    Author
  8. name
    Cruz O
    type
    Author
  9. name
    Nysom K
    type
    Author
  10. name
    Berghorn E
    type
    Author
  11. name
    Simsek B
    type
    Author
  12. name
    Shen J
    type
    Author
bibliography ids
  1. nci-bib-6e523e9d32b2be4b405d363b
book metadata
content sha256
8e70831b74450bfffa583b90d718db63b453024fca22592703561c8582e15278
document type
citation
dois
  1. 10.1016/j.ejca.2017.09.032
electronic publication date
display
2017 Nov 5
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:29100190
immutable id
pubmed:29100190@8e70831b74450bfffa583b90d718db63b453024fca22592703561c8582e15278
journal
abbreviation
Eur J Cancer
issn electronic
1879-0852
issn print
0959-8049
issue
Source null
name
European journal of cancer (Oxford, England : 1990)
nlm unique id
9005373
pages
358-363
volume
86
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Eur J Cancer. 2018 May;95:117-119. doi: 10.1016/j.ejca.2018.01.080.
    note
    Source null
    related pmid
    29475773
    relationship
    Comment in
outcomes validated
false
pmid
29100190
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
bc89c6288f01275436c82ba9e48e4a0e96b5afc147acedac04adf4704d0b6a26
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2017 Nov
precision
month
year
2017
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
  5. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29100190/
title
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma.

Preserved source evidence · Not medical advice